LT2613772T - Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu - Google Patents

Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu

Info

Publication number
LT2613772T
LT2613772T LTEP11757811.2T LT11757811T LT2613772T LT 2613772 T LT2613772 T LT 2613772T LT 11757811 T LT11757811 T LT 11757811T LT 2613772 T LT2613772 T LT 2613772T
Authority
LT
Lithuania
Prior art keywords
low
drug release
transdermal patches
high drug
dose transdermal
Prior art date
Application number
LTEP11757811.2T
Other languages
English (en)
Inventor
Ildiko Terebesi
Christian Zurth
Hannes-Friedrich Ulbrich
Original Assignee
Bayer Intellectual Property Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2613772(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Intellectual Property Gmbh filed Critical Bayer Intellectual Property Gmbh
Publication of LT2613772T publication Critical patent/LT2613772T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
LTEP11757811.2T 2010-09-06 2011-09-05 Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu LT2613772T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10175498 2010-09-06
EP11155469 2011-02-22
PCT/EP2011/065261 WO2012031999A2 (en) 2010-09-06 2011-09-05 Low-dose transdermal patches with high drug release

Publications (1)

Publication Number Publication Date
LT2613772T true LT2613772T (lt) 2017-03-27

Family

ID=44653287

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11757811.2T LT2613772T (lt) 2010-09-06 2011-09-05 Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu

Country Status (19)

Country Link
US (1) US8671945B2 (lt)
EP (1) EP2613772B1 (lt)
CN (1) CN103189064B (lt)
AR (1) AR082906A1 (lt)
CY (1) CY1118684T1 (lt)
DK (1) DK2613772T3 (lt)
ES (1) ES2617334T3 (lt)
HK (1) HK1186968A1 (lt)
HR (1) HRP20170292T1 (lt)
HU (1) HUE031326T2 (lt)
LT (1) LT2613772T (lt)
ME (1) ME02618B (lt)
PL (1) PL2613772T3 (lt)
PT (1) PT2613772T (lt)
RS (1) RS55681B1 (lt)
SI (1) SI2613772T1 (lt)
TW (1) TW201215393A (lt)
UY (1) UY33593A (lt)
WO (1) WO2012031999A2 (lt)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
CH674618A5 (lt) 1987-04-02 1990-06-29 Ciba Geigy Ag
WO1990004397A1 (de) 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
WO1992007590A1 (en) 1990-10-29 1992-05-14 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE19527925C2 (de) * 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
DE19827732A1 (de) 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
TWI287455B (en) 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
EP1406633B1 (en) * 2001-06-18 2011-10-05 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
ATE333271T1 (de) * 2003-02-21 2006-08-15 Schering Ag Uv-stabiles transdermales pflaster
EP1660294B1 (en) 2003-08-25 2008-12-03 BFS Diversified Products, LLC Method and apparatus to monitor the compressive strength of insulation boards
EP1541136A1 (de) 2003-12-10 2005-06-15 Schering AG UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
MXPA06006682A (es) 2003-12-12 2006-08-11 Schering Ag Hormonas de administracion transdermica que no necesitan potenciadores de penetracion.
EP1719504A1 (de) 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
KR20110082142A (ko) 2008-10-06 2011-07-18 밀란 테크놀로지즈 인코포레이티드 비정질 로티고틴 경피 시스템

Also Published As

Publication number Publication date
ME02618B (me) 2017-06-20
US20120073578A1 (en) 2012-03-29
EP2613772B1 (en) 2016-12-14
EP2613772A2 (en) 2013-07-17
UY33593A (es) 2012-04-30
AR082906A1 (es) 2013-01-16
CY1118684T1 (el) 2017-07-12
WO2012031999A3 (en) 2012-08-02
TW201215393A (en) 2012-04-16
HK1186968A1 (en) 2014-03-28
CN103189064A (zh) 2013-07-03
CN103189064B (zh) 2015-08-12
DK2613772T3 (en) 2017-03-06
PT2613772T (pt) 2017-03-06
SI2613772T1 (sl) 2017-03-31
US8671945B2 (en) 2014-03-18
HRP20170292T1 (hr) 2017-04-21
PL2613772T3 (pl) 2017-06-30
HUE031326T2 (hu) 2017-07-28
ES2617334T3 (es) 2017-06-16
RS55681B1 (sr) 2017-07-31
WO2012031999A2 (en) 2012-03-15

Similar Documents

Publication Publication Date Title
IL222226A0 (en) Transdermal delivery patch
EP2424611A4 (en) DEVICE FOR TRANSDERMAL ADMINISTRATIONS
EP2561865A4 (en) PREPARATION FOR TRANSDERMAL ABSORPTION
EP2425827A4 (en) TRANSDERMALES PREPARATION
EP2687205A4 (en) TRANSDERMAL STAMP CONTAINING FENTANYL
EP2564848A4 (en) TRANSDERMAL ABSORBABLE DON-PEPPER PREPARATION
PL3023120T3 (pl) Aparaty do podawania leków przez skórę
EP2399607A4 (en) TRANSDERMALE PREPARATION
PL2554168T3 (pl) Kompozycja farmaceutyczna do kontrolowanego uwalniania
EP2438917A4 (en) TRANSDERMALES PREPARATION
GB201008448D0 (en) Transdermal device
EP2898879A4 (en) TRANSDERMAL STAMP HOLDER FOR SQUEEES OR TAPPING PHARMACEUTICAL PRODUCT, AND TANNING TRANSDERMAL STAMP AND THERAPEUTIC PHARMACEUTICAL PRODUCT USING THE SAME
EP2586324A4 (en) TRANSDERMAL ADMINISTRATION BRACELET
HK1186099A1 (zh) 透皮貼劑
EP2760438A4 (en) SYSTEM FOR REMOVAL OF SKIN STAMPS
EP2671572A4 (en) TRANSDERMAL STAMP AND PREPARATION OF TRANSDERMAL STAMP
EP2671573A4 (en) PLASTER AND PAVER MAKING
GB201115920D0 (en) Multi-layered transdermal patch
EP2564852A4 (en) MEDICAMENT TREATING CEREBRAL TUMORS
ZA201301389B (en) Transdermal therapeutic system with crystallization-inhibiting protectitive film (release liner)
HK1186968A1 (en) Low-dose transdermal patches with high drug release
HK1198419A1 (en) Transdermal patch
HK1181999A1 (en) Transdermal absorption preparation
GB201016615D0 (en) Drug release composition
GB201001335D0 (en) Drug release formulations